Back to homepage
Skip navigation
Faslodex Home
News and features
Faslodex overview
Prescribing information
Pharmacology
Efficacy and tolerability
IM administration
Clinical trials
Expert views
Case studies
Key publications
Slide library
Information for your patients
Congress Calendar
Congress Reports
Glossary
Links
Contact us
Home
Evaluation of fulvestrant in women with advanced breast cancer and progression on prior aromatase inhibitor therapy: a phase II trial of the North Central Cancer Treatment Group
Back
Authors:
Ingle JN, Suman VJ, Rowland KM et al.
Journal:
J Clin Oncol 2006; 24: 1052–1056
Click here to read the full article from the Journal of Clinical Oncology (external link)
AstraZeneca websites
Site services
Printer friendly
Search
Advanced Search
Site map
Faslodex.net features
BreastCancerSource
BreastcancerSource.com is an educational website containing information on breast cancer and its treatments intended for healthcare professionals, patients and carers.
Terms of use
Privacy policy
© AstraZeneca 2003-2007 (All rights reserved)
Home
